Tag: biotechnology
-
First Trial of Alzheimer’s Drug Underway
The first clinical trial is underway of a therapy for stopping the progression of Alzheimer’s disease that purports to rebuild neural connections in the brain.
-
Univ. Spin-Off Reports Cancer Immunotherapy Advance
A highly targeted synthetic antibody, developed by a university spin-off enterprise, was shown to destroy human breast cancer cells grafted in lab mice.
-
Online Game Harnessed to Combat Foodborne Toxins
A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops.
-
Roche, Biotech to Discover New Antibiotics
A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics.
-
Biotech Licenses Gene Editing for Autoimmune Disorders
A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases.
-
Neuro Disease Start-Up Gains $30M in Early Funds
A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round.
-
Avian Flu Vaccine with Longer Protection in Development
A biotechnology company is designing a vaccine to protect against the newly emergent avian flu to provide more sustained protection like seasonal flu vaccines.
-
Drug Delivery Technology Licensed in $2B Deals
The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers.
-
Synthetic DNA Start-Up Raises $13M in Early Funds
A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round.
-
Trial Shows Antibody Effective Against Asthma
Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning.